SCHEMBL7531909

SCHEMBL7531909

NC(=O)C(N)c1cccc(C(=O)c2ccc(Br)cc2)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.57
KMT2A Q03164 2/20 0.57
CTSL P07711 1/20 0.48
MAPT P10636 5/20 0.45
PTGS1 P23219 3/20 0.45
PTGS2 P35354 3/20 0.45
LMNA P02545 3/20 0.45
MAPK1 P28482 3/20 0.45
CXCR1 P25024 2/20 0.45
CXCR2 P25025 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
RECQL P46063 1/20 0.45
KDM4E B2RXH2 1/20 0.45
ALDH1A1 P00352 1/20 0.45
CYP3A4 P08684 1/20 0.45
HPGD P15428 1/20 0.45
PMP22 Q01453 1/20 0.45
SLC22A6 Q4U2R8 1/20 0.45
HSD17B10 Q99714 1/20 0.45
CXCL8 P10145 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL55801 0.88 MEN1 (0.54) MEN1KMT2ACTSLMAPTPTGS1
SCHEMBL3146429 0.87 MAPT (0.58) MEN1KMT2AMAPTPTGS1PTGS2
SCHEMBL57091 0.87 MEN1 (0.52) MEN1KMT2ACTSLMAPTPTGS1
SCHEMBL56645 0.85 MEN1 (0.48) MEN1KMT2ACTSLMAPTPTGS1
SCHEMBL93570 0.85 CTSL (0.48) MEN1KMT2ACTSLMAPTPTGS1
SCHEMBL94130 0.85 SMN1; SMN2 (0.45) MEN1KMT2AMAPTPTGS1PTGS2
Water SCHEMBL57566 0.84 MEN1 (0.47) MEN1KMT2ACTSLMAPTPTGS1
SCHEMBL7525588 0.83 ITGA1 (0.46) MEN1KMT2ACTSLMAPTPTGS1
SCHEMBL11227919 0.81 SRD5A2 (0.51) MAPTPTGS1PTGS2LMNAMAPK1
SCHEMBL3649122 0.79 PARP1 (0.50) SMN1; SMN2ALDH1A1HPGDPARP1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0716600-B1 TOPICALLY ADMINISTRABLE COMPOSITIONS CONTAINING 3-BENZOYLPHENYLACETIC ACID DERIVATIVES FOR TREATMENT OF OPHTHALMIC INFLAMMATORY DISORDERS ALCON LAB INC (US) 2002-04-03 EP claimed
EP-0716600-A1 TOPICALLY ADMINISTRABLE COMPOSITIONS CONTAINING 3-BENZOYLPHENYLACETIC ACID DERIVATIVES FOR TREATMENT OF OPHTHALMIC INFLAMMATORY DISORDERS ALCON LABORATORIES, INC. (US) 1996-06-19 EP claimed
WO-1995033457-A1 TOPICALLY ADMINISTRABLE COMPOSITIONS CONTAINING 3-BENZOYLPHENYLACETIC ACID DERIVATIVES FOR TREATMENT OF OPHTHALMIC INFLAMMATORY DISORDERS ALCON LABORATORIES, INC. (US) 1995-12-14 WO claimed
US-5475034-A Adminstering 3-benzoylphenylacetamide derivatives ALCON LABORATORIES, INC. (US) 1995-12-12 US claimed
EP-0716600-B1 TOPICALLY ADMINISTRABLE COMPOSITIONS CONTAINING 3-BENZOYLPHENYLACETIC ACID DERIVATIVES FOR TREATMENT OF OPHTHALMIC INFLAMMATORY DISORDERS ALCON LAB INC (US) 2002-04-03 EP disclosed
EP-0716600-A1 TOPICALLY ADMINISTRABLE COMPOSITIONS CONTAINING 3-BENZOYLPHENYLACETIC ACID DERIVATIVES FOR TREATMENT OF OPHTHALMIC INFLAMMATORY DISORDERS ALCON LABORATORIES, INC. (US) 1996-06-19 EP disclosed
WO-1995033457-A1 TOPICALLY ADMINISTRABLE COMPOSITIONS CONTAINING 3-BENZOYLPHENYLACETIC ACID DERIVATIVES FOR TREATMENT OF OPHTHALMIC INFLAMMATORY DISORDERS ALCON LABORATORIES, INC. (US) 1995-12-14 WO disclosed
US-5475034-A Adminstering 3-benzoylphenylacetamide derivatives ALCON LABORATORIES, INC. (US) 1995-12-12 US disclosed